Cargando…
POS-853 AKI due to COVID-19 disease requiring Renal Replacement Therapy: role of Expanded HaemoDialisys (HDx) on inflammation and outcome
Autores principales: | Gernone, G., Detomaso, F., Partipilo, F., Montemurro, M., Procino, F., Diele, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854924/ http://dx.doi.org/10.1016/j.ekir.2022.01.891 |
Ejemplares similares
-
POS-012 RISK FACTORS FOR AKI AND MORTALITY IN COVID-19 IN WESTERN MEXICO
por: GARCIA RIVERA, A., et al.
Publicado: (2022) -
Diálisis
Publicado: (2001) -
Fundamentals of HDX-MS
por: Vinciauskaite, Vanesa, et al.
Publicado: (2023) -
First experience of a hemophilia monitoring platform: florio HAEMO
por: Zapotocka, Ester, et al.
Publicado: (2022) -
POS-326 AKI IS A USEFUL PREDICTOR OF POOR OUTCOMES IN COVID-19
por: JACKSON, D., et al.
Publicado: (2021)